- Home
- Companies
- united kingdom
- myocardial infarction
Refine by
Myocardial Infarction Suppliers In United Kingdom
5 companies found
based inHouston, TEXAS (USA)
LivaNova is a global medical technology company built on decades of experience and a relentless commitment to patients. Our focus is transforming lives with products and therapies for the head and heart. It’s health innovation that truly matters. ...
The extraordinarily innovative, intuitive and powerful autotransfusion ...
based inLeeds, UNITED KINGDOM
Founded in 2009, Leeds-based Arterius is developing a next-generation bioresorbable cardiovascular scaffold (stent) with an emerging market-leading clinical profile. The founding directors have significant experience in the development of medical ...
based inBelfast, UNITED KINGDOM
Biopanda Reagents develops and manufactures in vitro test kits for clinical laboratories, veterinary practice, environmental protection, and food safety, both locally and globally. Our company provides innovative, high quality and cost-effective ...
This Point-of-Care rapid test, is a rapid chromatographic immunoassay, for the qualitative detection of human H-FABP in whole blood (venipuncture or fingerstick blood), serum, or plasma samples. Results are available in 10 minutes, to assist health ...
based inShipley, UNITED KINGDOM
Our founders have more than 50 years of experience in the field of protein and antibody research. They are experts in this niche market and the main purpose behind the creation of this company was to offer customers with the highest quality ...
Human ANP ELISA kit is a procedure intended for determining in vitro quantitative amounts of atrial natriuretic peptide (ANF, ANH, ANP) in human serum, cell lysates, plasma, other biological fluids and cell culture ...
based inDaresbury, UNITED KINGDOM
Point of Care (PoC) medical diagnostics is a $ multi-billion global market. Driven by patient need for self monitoring and healthcare cost savings, hand-held devices or readers offering rapid diagnostic test results are fast replacing often slow and ...
Bio-AMD’s planned Generic PoC Magnetic Immunoassay Detection System (‘MIDS’), is expected to have a significantly enhanced sensitivity based on magnetic nano-particle manipulation and detection, capable of interpreting results on a ...
